Hematologic Malignancy
Lymphoid Leukemia
CI-CAN-00001101Explore in graph →
Hematologic827 active trials20 approved drugs95 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001101Explore in graph →
Clinical trials
3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (489)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01199575 | Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 30 | University of California, San DiegoOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05326516 | A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia | completed | Phase 1 | 30 | Syndax PharmaceuticalsINDUSTRY | 2 | Aug 13, 2024 | clinicaltrials |
| NCT03275636 | Haploidentical Donor vs mMUD in Hematological Malignancies(HAMLET) | completed | Phase 2 / Phase 3 | 98 | DKMS gemeinnützige GmbHOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT06527781 | A Study of PD5K3 in Healthy Adult Volunteers | completed | Phase 1 | 28 | Chongqing Peg-Bio Biopharm Co., Ltd.INDUSTRY | 1 | Jul 30, 2024 | clinicaltrials |
| NCT02920697 | Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma | completed | Phase 1 | 65 | Institut de Recherches Internationales ServierOTHER | 8 | Jul 25, 2024 | clinicaltrials |
| NCT04311216 | Shoulder Instability in Children: Muscle Activity and Movement | completed | — | 30 | Robert Jones and Agnes Hunt Orthopaedic and District NHS TrustOTHER_GOV | 1 | Jul 22, 2024 | clinicaltrials |
| NCT05250869 | Comparative Quantification of MTX and Its Metabolites Post Glucarpidase | completed | — | 4 | Charite University, Berlin, GermanyOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT01523977 | Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL(CRAD001NUS175T) | completed | Phase 1 | 22 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05850013 | The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care(VISION-Jr) | completed | — | 504 | Xim LimitedINDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT00557193 | Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | completed | Phase 3 | 218 | Children's Oncology GroupNETWORK | 4 | Jul 15, 2024 | clinicaltrials |
| NCT06489236 | Effectiveness of an Intervention on Vaccine Hesitancy Among Pediatric Nurses and Pediatricians | completed | N/A | 142 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT04969601 | Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings(PACIFIC) | completed | Phase 1 / Phase 2 | 76 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT02199184 | Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia | completed | Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT03471416 | Nutritional Status in Children With ALL in Guatemala | completed | — | 109 | Columbia UniversityOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT02836886 | VircapSeq Virus Detection in Sézary Syndrome | completed | — | 6 | Columbia UniversityOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT05064787 | Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy | completed | N/A | 45 | Pack HealthINDUSTRY | 1 | May 24, 2024 | clinicaltrials |
| NCT05422937 | Symptom Patterns and Life With Longer Term COVID-19 in Children and Young People (SPLaT-19 Cohort & Qualitative Study)(SPLaT-19) | completed | — | 502 | Keele UniversityOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT03463694 | Edinburgh and Lothian Virus Intervention Study in Kids(ELVIS Kids) | completed | N/A | 407 | University of EdinburghOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT05928104 | Optimising Pharmacist-led Medication Reviews in Primary Care(OPen) | completed | — | 15 | University of East AngliaOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT04942730 | Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)(FluBuBe) | completed | Phase 2 | 50 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT01597219 | Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers(UK-Haplo) | completed | Phase 2 | 77 | University College, LondonOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03892044 | Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma | completed | Phase 1 | 7 | David Bond, MDOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06392763 | Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data | completed | — | 602 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 30, 2024 | clinicaltrials |
| NCT00457782 | A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma | completed | Phase 1 | 27 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Apr 25, 2024 | clinicaltrials |
| NCT05433532 | Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients | completed | Phase 2 | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06179732 | Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities | completed | Phase 3 | 2,400 | The Mentor InitiativeOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT01397916 | Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)(KLL3) | completed | — | 73 | Tampere University HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06376188 | Improving Breaking Bad News in Pediatrics by Simulated Communication(SimCom) | completed | N/A | 46 | Medical University of ViennaOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06110702 | Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms(MDL) | completed | N/A | 287 | University of PisaOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03881228 | Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old | completed | N/A | 356 | Universidad Peruana Cayetano HerediaOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT02100423 | Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | completed | Phase 2 | 35 | Paolo Caimi, MDOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT02340884 | A Pilot RCT of the PRISM Intervention for AYAs With Cancer | completed | Phase 2 | 92 | Seattle Children's HospitalOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT04524455 | Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL | completed | Phase 1 | 17 | AmgenINDUSTRY | 9 | Apr 8, 2024 | clinicaltrials |
| NCT04666025 | SARS-CoV-2 Donor-Recipient Immunity Transfer | completed | — | 26 | City of Hope Medical CenterOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT04554485 | Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)(Blina-CELL) | completed | Phase 2 | 27 | Institute of Hematology and Blood Transfusion, Czech RepublicOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT05810532 | NPO Before Sedation | completed | N/A | 68 | Kangbuk Samsung HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT01588015 | Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant | completed | Phase 1 | 36 | City of Hope Medical CenterOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06338020 | Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic Leukemia | completed | N/A | 62 | Cairo UniversityOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT01028430 | B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging | completed | — | 1,000 | Northwell HealthOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT01030913 | B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression | completed | — | 1,248 | Northwell HealthOTHER | 1 | Mar 27, 2024 | clinicaltrials |
| NCT00381680 | Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia | completed | Phase 3 | 275 | Children's Oncology GroupNETWORK | 4 | Mar 26, 2024 | clinicaltrials |
| NCT04664608 | Pediatric EEG Monitoring | completed | — | 30 | Northwestern UniversityOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT03056339 | Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies | completed | Phase 1 / Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT04051216 | The SMART CART Study: Health Information Technology | completed | N/A | 148 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT02420912 | Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation | completed | Phase 2 | 37 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT01386619 | NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) | completed | Phase 1 / Phase 2 | 15 | University Hospital, Basel, SwitzerlandOTHER | 2 | Mar 19, 2024 | clinicaltrials |
| NCT03267030 | Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase | completed | Phase 2 | 55 | Birgitte Klug AlbertsenOTHER | 6 | Mar 15, 2024 | clinicaltrials |
| NCT03771157 | Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors | completed | Early Phase 1 | 33 | University of RochesterOTHER | 1 | Mar 15, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 15, 2024source: clinicaltrials